Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model

Background: Our previous findings showed that BCc1, a nanoparticle designed based on nanochelating technology, can be considered a new anti-cancer nanoparticle if confirmed by complementary studies. Goal: In the present study, we investigated the effects of the BCc1 nanoparticle alone on some gene e...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Onco Targets Ther
Auteurs principaux: Hafizi, Maryam, Soleimani, Masoud, Noorian, Sajad, Kalanaky, Somayeh, Fakharzadeh, Saideh, Tavakolpoor Saleh, Nafiseh, Nazaran, Mohammad Hassan, Akbari, Mohammad Esmaeil
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590627/
https://ncbi.nlm.nih.gov/pubmed/31354301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S200446
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires